Bio industry company Zenenbio announced on the 9th that the shareholding ratio of Genexin and its special related parties decreased from 20.87% to 20.23%.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing